Nvidia Equity Method Investments increased by 115.5% to $8.19B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 266.0%, from $2.24B to $8.19B. Over 2 years (FY 2024 to FY 2026), Equity Method Investments shows an upward trend with a 183.4% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $288.00M | $496.00M | $676.00M | $1.02B | $1.32B | $1.46B | $1.82B | $2.24B | $3.39B | $3.24B | $3.80B | $8.19B |
| QoQ Change | — | +72.2% | +36.3% | +50.7% | +29.6% | +10.7% | +24.3% | +23.0% | +51.4% | -4.3% | +17.3% | +115.5% |
| YoY Change | — | — | — | — | +358.7% | +195.0% | +169.1% | +119.5% | +156.4% | +121.5% | +108.9% | +266.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.